SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-035111
Filing Date
2015-02-05
Accepted
2015-02-05 13:44:02
Documents
2
Group Members
ANSBERT GADICKEJAMES PAUL SCOPALUKE EVNINMPM BIOVENTURES IV GP LLCMPM BIOVENTURES IV LLCTODD FOLEYVAUGHN M. KAILIAN

Document Format Files

Seq Description Document Type Size
1 SC 13G d868235dsc13g.htm SC 13G 151887
2 EX-A d868235dex99a.htm EX-99.A 14312
  Complete submission text file 0001193125-15-035111.txt   167964
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88372 | Film No.: 15579349
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET 54TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET 54TH FLOOR BOSTON MA 02116 617-425-9200
MPM Bio IV NVS Strategic Fund LP (Filed by) CIK: 0001423213 (see all company filings)

IRS No.: 980508803 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G